Automated Health Systems competitors

Chris has been with CPSI since 2000 and transitioned to his current CPSI role in 2015. He also serves as President at TruBridge, a role he has held since 2013. Chris previously served as Vice President of Business Services from 2008-2013. Other previously-held positions include Assistant Director and Director in the Business Management Services division. Chris graduated from Auburn University with a Bachelor of Science in Marketing.

Yousuf Ahmad is a Chief Executive Officer at AssureCare LLC. He has worked as Senior VP:System Development at Mercy Medical Center.

Amar A. Desai, MD is a President and Chief Executive Officer, Optum Pacific West at Optum and Associate Clinical Professor of Medicine at Keck School of Medicine of USC and is based in Greater Los Angeles Area. He has worked as Vice President, Strategic Development at DaVita; Chief Medical Officer at Paladina Health; and Adjunct Clinical Instructor at Stanford University School of Medicine. Amar works or has worked as President- Healthcare Partners California- Coastal Region at DaVita. He studied at Harvard T.H. Chan School of Public Health between 2000 and 2002, Brown University between 1993 and 1997, and Warren Alpert Medical School of Brown University between 1997 and 2002.

Influential and Strategic Executive with a sustained record of driving the full sales and development life cycles of PBM services, enterprise software and robotic fulfillment technology solutions to the largest and most recognized global brands impacting KPIs across all areas of clients’ operations. Consistently effective in assessing market needs/trends, forging relationships with C-level decision makers and building/transforming high-performing sales organizations. Excel in designing mission, vision and road map to reposition mid-level companies into industry leaders in the hospital, retail and federal government pharmacy arenas. Skilled in identifying and developing top-tier talent. In depth knowledge of all areas of technology for pharmacy including large capital projects with SaaS and industry leading robotic disruptive technology. Focused on technology and its application and role in patient facing pharmacy models. Big picture understanding of the pharmacy space with continual evolutionary planning for new technology development and integration of solution sets. Directly and indirectly involved in excess of $4.5 billion dollars in sales annually. Responsible for international market expansion in the Pacific Rim, Central America, Gulf Region and Canada. Secured distribution contracts for multiple product lines. Drove new product development in key emerging markets. Created new disruptive market approach for evolving segments.